Cargando…

Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India

AIM: Many pediatric cancer patients undergo repeated bone marrow aspirations (BMAs) for diagnostic and treatment evaluation purposes. Full anesthesia is the standard of care during this procedure in high-income countries. At hospitals with low resources in low/middle-income countries many children u...

Descripción completa

Detalles Bibliográficos
Autores principales: Rayala, Spandana, Kyander, Melker, Haridass, Vikranth, Palat, Gayatri, Ström, Axel, Wiebe, Thomas, Brun, Eva, Segerlantz, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812415/
https://www.ncbi.nlm.nih.gov/pubmed/31673202
http://dx.doi.org/10.4103/IJPC.IJPC_110_19
_version_ 1783462655233622016
author Rayala, Spandana
Kyander, Melker
Haridass, Vikranth
Palat, Gayatri
Ström, Axel
Wiebe, Thomas
Brun, Eva
Segerlantz, Mikael
author_facet Rayala, Spandana
Kyander, Melker
Haridass, Vikranth
Palat, Gayatri
Ström, Axel
Wiebe, Thomas
Brun, Eva
Segerlantz, Mikael
author_sort Rayala, Spandana
collection PubMed
description AIM: Many pediatric cancer patients undergo repeated bone marrow aspirations (BMAs) for diagnostic and treatment evaluation purposes. Full anesthesia is the standard of care during this procedure in high-income countries. At hospitals with low resources in low/middle-income countries many children undergo these painful procedures without sufficient pain relief. This study aimed to evaluate the usefulness of low-dose oral ketamine as a procedural analgesic in a low-resource pediatric cancer care department. MATERIALS AND METHODS: Pediatric patients, 4–15 years of age, who underwent BMAs between September 31 and November 30, 2018, were invited to participate. The study was designed as a placebo-controlled, single-blinded trial with three trial groups. Group K received 1.0 mg/kg of ketamine and Group KM received 1.0 mg/kg ketamine with an addition of 0.2 mg/kg midazolam, mixed in juice 30 min before procedures. Group P received placebo consisting of plain juice. All three groups also received the hospital's current standard treatment for procedural pain in BMAs. Patients and caregivers assessed the procedural pain, as did the performing doctors. For the patients, Faces Pain Scale – Revised was used and the Numeric Rating Scale-11 for caregivers and doctors. RESULTS: A total of 87 patients were included in the study distributed with 29 in Group K, 29 in Group KM, and 29 in Group P. Seven patients were excluded, one patient denied participation and the remaining did not meet the inclusion criteria. There was no significant difference between the pain reported by the groups. A total of 69% patients in Group KM and 35% in Group K had somnolence reported as a side effect compared to 14% in Group P. CONCLUSION: We found no significant effects on the procedural pain in any of the treatment groups compared to placebo. There were only mild side effects. The doses of ketamine might be insufficient for this painful and stressful procedure.
format Online
Article
Text
id pubmed-6812415
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-68124152019-10-31 Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India Rayala, Spandana Kyander, Melker Haridass, Vikranth Palat, Gayatri Ström, Axel Wiebe, Thomas Brun, Eva Segerlantz, Mikael Indian J Palliat Care Original Article AIM: Many pediatric cancer patients undergo repeated bone marrow aspirations (BMAs) for diagnostic and treatment evaluation purposes. Full anesthesia is the standard of care during this procedure in high-income countries. At hospitals with low resources in low/middle-income countries many children undergo these painful procedures without sufficient pain relief. This study aimed to evaluate the usefulness of low-dose oral ketamine as a procedural analgesic in a low-resource pediatric cancer care department. MATERIALS AND METHODS: Pediatric patients, 4–15 years of age, who underwent BMAs between September 31 and November 30, 2018, were invited to participate. The study was designed as a placebo-controlled, single-blinded trial with three trial groups. Group K received 1.0 mg/kg of ketamine and Group KM received 1.0 mg/kg ketamine with an addition of 0.2 mg/kg midazolam, mixed in juice 30 min before procedures. Group P received placebo consisting of plain juice. All three groups also received the hospital's current standard treatment for procedural pain in BMAs. Patients and caregivers assessed the procedural pain, as did the performing doctors. For the patients, Faces Pain Scale – Revised was used and the Numeric Rating Scale-11 for caregivers and doctors. RESULTS: A total of 87 patients were included in the study distributed with 29 in Group K, 29 in Group KM, and 29 in Group P. Seven patients were excluded, one patient denied participation and the remaining did not meet the inclusion criteria. There was no significant difference between the pain reported by the groups. A total of 69% patients in Group KM and 35% in Group K had somnolence reported as a side effect compared to 14% in Group P. CONCLUSION: We found no significant effects on the procedural pain in any of the treatment groups compared to placebo. There were only mild side effects. The doses of ketamine might be insufficient for this painful and stressful procedure. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6812415/ /pubmed/31673202 http://dx.doi.org/10.4103/IJPC.IJPC_110_19 Text en Copyright: © 2019 Indian Journal of Palliative Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Rayala, Spandana
Kyander, Melker
Haridass, Vikranth
Palat, Gayatri
Ström, Axel
Wiebe, Thomas
Brun, Eva
Segerlantz, Mikael
Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India
title Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India
title_full Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India
title_fullStr Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India
title_full_unstemmed Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India
title_short Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India
title_sort low-dose oral ketamine as a procedural analgesia in pediatric cancer patients undergoing bone marrow aspirations at a resource-limited cancer hospital in india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812415/
https://www.ncbi.nlm.nih.gov/pubmed/31673202
http://dx.doi.org/10.4103/IJPC.IJPC_110_19
work_keys_str_mv AT rayalaspandana lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia
AT kyandermelker lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia
AT haridassvikranth lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia
AT palatgayatri lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia
AT stromaxel lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia
AT wiebethomas lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia
AT bruneva lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia
AT segerlantzmikael lowdoseoralketamineasaproceduralanalgesiainpediatriccancerpatientsundergoingbonemarrowaspirationsataresourcelimitedcancerhospitalinindia